Xospata 40 mg/1

Xospata 40 mg tablets contain gilteritinib, a medication used in cancer treatment. This oral tablet is manufactured by Astellas Pharma US, Inc. and is available in a 90-tablet bottle.

Xospata 40 mg tablets are primarily used in the treatment of certain types of cancer. Gilteritinib, the active ingredient, is often prescribed for patients who have specific genetic markers. This medication is part of a broader category of drugs known as targeted therapies, which work by interfering with the growth and spread of cancer cells. Patients and healthcare providers should discuss the specific uses of Xospata 40 mg tablets, including what gilteritinib is used for in individual cases.

Common effects of Xospata 40 mg tablets may include fatigue, nausea, and changes in blood cell counts. Some patients may experience muscle pain, fever, or difficulty breathing. It is important to note that individual responses to gilteritinib can vary, and not everyone will experience these effects. Patients should report any persistent or severe symptoms to their healthcare provider.

Xospata 40 mg tablets should be handled with care and stored as directed. This medication is intended for oral use only and should be taken exactly as prescribed. Patients should avoid breaking or crushing the tablets unless instructed to do so. It is crucial to follow the storage instructions provided to maintain the effectiveness of gilteritinib. Always consult a healthcare provider before starting or stopping any medication.

Xospata 40 mg tablets may interact with certain medications, including those that affect liver enzymes. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol and other substances that affect liver function may also interact with gilteritinib. It is important to discuss potential interactions with a healthcare provider to ensure safe and effective use of Xospata 40 mg tablets.